To clarify my previous post I see they also slipped in that they are first off the ranks for SAMR review. Still, the title of release is about CNCA so you would expect BAL to follow suit?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025